Chad Johnson
Direktor/Vorstandsmitglied bei LUMOS PHARMA, INC.
Vermögen: 2 970 $ am 30.04.2024
Profil
Chad Allen Johnson is currently an Independent Director at Lumos Pharma, Inc. He previously served as an Independent Director at NewLink Genetics Corp.
and as the Senior Corporate Counsel & Assistant Secretary at Renewable Energy Group, Inc. from 2015 to 2017.
He also worked as the General Counsel at Stine Seed Co. Mr. Johnson holds a graduate degree from Iowa State University and a graduate degree from Drake University Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LUMOS PHARMA, INC.
0,01% | 01.03.2024 | 1 076 ( 0,01% ) | 2 970 $ | 30.04.2024 |
Aktive Positionen von Chad Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
| LUMOS PHARMA, INC. | Direktor/Vorstandsmitglied | 01.03.2018 |
Ehemalige bekannte Positionen von Chad Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| RENEWABLE ENERGY GROUP, INC. | General Counsel | 01.04.2017 |
Stine Seed Co.
 Stine Seed Co. Agricultural Commodities/MillingProcess Industries Stine Seed Co. supplies and distributes variety of seeds. It provides corn and soybeans seeds. The firm also engages in various research works such as aerosol beam injector, genetics and biotech laboratory, and corn and soybean breeding program. The company was founded by Harry H. Stine in 1964 and is headquartered in Adel, IA. | General Counsel | - |
| LUMOS PHARMA, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Chad Johnson
| Iowa State University | Graduate Degree |
| Drake University Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LUMOS PHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Stine Seed Co.
Stine Seed Co. Agricultural Commodities/MillingProcess Industries Stine Seed Co. supplies and distributes variety of seeds. It provides corn and soybeans seeds. The firm also engages in various research works such as aerosol beam injector, genetics and biotech laboratory, and corn and soybean breeding program. The company was founded by Harry H. Stine in 1964 and is headquartered in Adel, IA. | Process Industries |
Renewable Energy Group, Inc.
 Renewable Energy Group, Inc. Chemicals: SpecialtyProcess Industries Renewable Energy Group, Inc. is a holding company engaged in the production and trade of biofuel and renewable chemicals. It operates through the following segments: Biomass-based Diesel and Services. The Biomass-based Diesel segment processes waste vegetable oils, animal fats, virgin vegetable oils and other feedstocks and methanol into biomass-based diesel. The Services segment offers services for managing the construction of biomass-based diesel production facilities and managing ongoing operations of third-party plants and collects fees related to the services provided. The company was founded in August 2006 and is headquartered in Ames, IA. | Process Industries |
